Trial intelligence / Profile preview

Effects of Dose and Injection Site for Gummy Smile Treatment With Botulinum Type A

NCT04820543Phase 4Completed

Sponsor
Peking University
Start
Feb 2019
Primary completion
Nov 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in excessive gingival display, sponsored by Peking University. Started Feb 2019; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

excessive gingival display

Beyond the preview

Go deeper on NCT04820543.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04820543.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call